Inner Mongolia Furui Medical Science Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Guanyi Wang

Chief Executive Officer (CEO)

CN¥300.0k

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	1.3yrs
Participación del CEO	11.2%
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	4.3yrs

Actualizaciones recientes de la dirección

Recent updates

Here's Why We Think Inner Mongolia Furui Medical Science (SZSE:300049) Might Deserve Your Attention Today

Sep 02

Inner Mongolia Furui Medical Science Co., Ltd.'s (SZSE:300049) Intrinsic Value Is Potentially 30% Above Its Share Price

Jul 21

With EPS Growth And More, Inner Mongolia Furui Medical Science (SZSE:300049) Makes An Interesting Case

May 24

We Think Inner Mongolia Furui Medical Science (SZSE:300049) Can Manage Its Debt With Ease

Apr 29

Investors Still Waiting For A Pull Back In Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049)

Feb 28

CEO

Guanyi Wang (54 yo)

1.3yrs

Permanencia

CN¥300,000

Compensación

Mr. Guanyi Wang serves as the Chairman of Inner Mongolia Free Han & Mongolia Pharmaceutical Co. Ltd and serves as its General Manager since May 17, 2023.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Guanyi Wang	GM & Chairman	no data	CN¥300.00k	11.18% CN¥ 1.3b
Yong Yang	Deputy GM & Director	4.3yrs	CN¥783.00k	0.089% CN¥ 10.2m
Lijuan Deng	Deputy GM & Director	4.3yrs	CN¥1.02m	0.038% CN¥ 4.3m
Li Qun Wang	Chairman of the Supervisory Board	13.6yrs	CN¥60.00k	0.041% CN¥ 4.7m
Jinlong Guo	Independent Director	4.3yrs	CN¥60.00k	sin datos
Fangyuan Geng	Independent Director	4.3yrs	CN¥60.00k	sin datos
Dandan Wang	Employee Representative Supervisor	4.3yrs	sin datos	0.021% CN¥ 2.4m
Hao Chen	Non-Employee Representative Supervisor	4.3yrs	sin datos	sin datos
Ru Wang	Employee Representative Supervisor	7.4yrs	sin datos	sin datos
Lang Tian	Employee Representative Supervisor	3.4yrs	sin datos	sin datos
Zhe Li	Non-Independent Director	1.3yrs	sin datos	sin datos
Peng Guo	Independent Director	2.3yrs	CN¥60.00k	sin datos

4.3yrs

Permanencia media

51.5yo

Promedio de edad

Junta con experiencia: La junta directiva de 300049 se considera experimentada (3.9 años de antigüedad promedio).

Inner Mongolia Furui Medical Science Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Inner Mongolia Furui Medical Science Co., Ltd., Annual General Meeting, May 21, 2024

High number of new directors

High number of new directors

Recent updates

Second quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.12 in 2Q 2023)

Here's Why We Think Inner Mongolia Furui Medical Science (SZSE:300049) Might Deserve Your Attention Today

Inner Mongolia Furui Medical Science Co., Ltd.'s (SZSE:300049) Intrinsic Value Is Potentially 30% Above Its Share Price

Now 21% undervalued

Inner Mongolia Furui Medical Science Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

With EPS Growth And More, Inner Mongolia Furui Medical Science (SZSE:300049) Makes An Interesting Case

Inner Mongolia Furui Medical Science Co., Ltd., Annual General Meeting, May 21, 2024

We Think Inner Mongolia Furui Medical Science (SZSE:300049) Can Manage Its Debt With Ease

First quarter 2024 earnings released: EPS: CN¥0.16 (vs CN¥0.049 in 1Q 2023)

Inner Mongolia Furui Medical Science Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024

Investors Still Waiting For A Pull Back In Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049)

Inner Mongolia Furui Medical Science Co., Ltd. to Report Fiscal Year 2023 Results on Apr 29, 2024

Price target increased by 41% to CN¥43.70

Third quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.11 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.091 in 2Q 2022)

Now 20% undervalued after recent price drop

New major risk - Share price stability

New major risk - Share price stability

Investor sentiment deteriorates as stock falls 20%

Inner Mongolia Furui Medical Science Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 13 June 2023

Inner Mongolia Furui Medical Science Co., Ltd. Approves Cash Dividend for 2022

First quarter 2023 earnings released: EPS: CN¥0.049 (vs CN¥0.033 in 1Q 2022)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

High number of new directors

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.11 (vs CN¥0.061 in 3Q 2021)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.091 (vs CN¥0.12 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

High number of new directors

Now 24% undervalued after recent price drop

Now 22% undervalued

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS CN¥0.061 (vs CN¥0.06 in 3Q 2020)

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS CN¥0.12 (vs CN¥0.018 in 2Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.049 (vs CN¥0.041 in 1Q 2020)

New 90-day low: CN¥7.17

New 90-day low: CN¥8.73

New 90-day low: CN¥9.65

Third quarter earnings released

New 90-day low: CN¥9.69

First half earnings released

Inner Mongolia Furui Medical Science Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

CEO

Permanencia

Compensación

Miembros de la Junta

Permanencia media

Promedio de edad